[New therapeutic strategies in chronic hepatitis C]

Gastroenterol Clin Biol. 2006 Aug-Sep;30(8-9):1009-11. doi: 10.1016/s0399-8320(06)73375-9.
[Article in French]
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • Hepacivirus / drug effects
  • Hepacivirus / enzymology
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins
  • Ribavirin / analogs & derivatives
  • Ribavirin / therapeutic use
  • Serine Proteinase Inhibitors / therapeutic use
  • Serum Albumin / therapeutic use
  • Serum Albumin, Human
  • Viral Proteins / antagonists & inhibitors
  • Viral Vaccines

Substances

  • Antiviral Agents
  • Immunoglobulins, Intravenous
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Serine Proteinase Inhibitors
  • Serum Albumin
  • Viral Proteins
  • Viral Vaccines
  • albuferon
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a
  • taribavirin
  • Serum Albumin, Human